Malignant Uterine Corpus Neoplasm — Trials

Malignant Uterine Corpus Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,571 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 411
Recruiting: 226
Ph III recruiting: 25
Growth YoY: +3.1%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.6%
Trials / 1,000 deaths: 50.2 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (168)

clinicaltrialsPublishedShowing 51–100 of 118 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05990426	Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy(FAST)	recruiting	N/A	30	Northwestern UniversityOTHER	1	Mar 24, 2026	clinicaltrials
NCT07480785	TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients	recruiting	N/A	780	Zhejiang UniversityOTHER	1	Mar 18, 2026	clinicaltrials